Cited by 598Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementAcute Ischemic Stroke Management

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.

National Trends in Ambulatory Oral Anticoagulant Use

Open access

Barnes, Geoffrey D., Lucas, Eleanor, Alexander, G. Caleb, Goldberger, Zachary D.·2015·The American Journal of Medicine

DOI 10.1016/j.amjmed.2015.05.044PMC PMC4658248

Open this paper in CoChat — free account Open PDF

Abstract

Background Four direct oral anticoagulants (DOACs) have been brought to market for the treatment of nonvalvular atrial fibrillation and venous thromboembolism. Many forces, including numerous positive trial results, emerging safety concerns, marketing, and promotion, may shape DOAC adoption by providers. However, relatively little is known regarding their ambulatory utilization compared with warfarin, as well as the degree to which they have decreased under-treatment of atrial fibrillation.Methods We used the IMS Health National Disease and Therapeutic Index, a nationally representative audit of outpatient office visits, to estimate the use of warfarin and DOACs between 2009 and 2014.Results Overall, visits with anticoagulation use increased from 2.05 (95% confidence interval [CI], 1.82-2.27) to 2.83 (95% CI, 2.49-3.17) million (M) quarterly visits (P < .001). Of these, DOAC use has grown to 4.21M (95% CI, 3.63M-4.79M; 38.2% of total) treatment visits in 2014 since their introduction in 2010. Use of all oral anticoagulants in treatment visits for atrial fibrillation has increased from 0.88M (95% CI, 0.74M-1.02M) to 1.72M (95% CI, 1.47M-1.97M; P < .001), with similar DOAC and warfarin use in 2014. Atrial fibrillation visits with anticoagulant use increased from 51.9% (95% CI, 50.4%-53.8%) to 66.9% (95% CI, 65.0%-69.3%) between 2009 and 2014 (P < .001). In 2014, rivaroxaban was the most commonly prescribed DOAC for atrial fibrillation (47.9% of office visits), followed by apixaban (26.5%) and dabigatran (25.5%).Conclusions Direct oral anticoagulants have been adopted rapidly, matching the use of warfarin, and are associated with increased use of oral anticoagulation for patients with atrial fibrillation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2015.05.044

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION
Tarver, T. (2014) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,595
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Cryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.025 · Cited by 929

Flagged first, then by citations

Show all 41 references

2 of the 41 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 597

Trends in Anticoagulant Use at Nursing Home Admission and Variation by Frailty and Chronic Kidney Disease Among Older Adults with Atrial Fibrillation
Campitelli, M. A., Bronskill, S. E., Huang, A., Maclagan, L. C., Atzema, C. L., Hogan, D. B., Lapane, K. L., Harris, D. A., & Maxwell, C. J. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00859-1 · Cited by 16
Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study
Jiang, S., Lv, M., Zeng, Z., Fang, Z., Chen, M., Qian, J., Wu, T., Chen, W., & Zhang, J. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02630-0 · Cited by 16
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016
Ardeshir‐Rouhani‐Fard, S., An, H., Goyal, R., Raji, M. A., Segal, J. B., Alexander, G. C., & Mehta, H. B. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2679 · Cited by 16
Self-citation
In vitro effects of a kaolin-coated hemostatic dressing on anticoagulated blood
Cripps, M. W., Cornelius, C. C., Nakonezny, P. A., Vazquez, N., Wey, J. C., & Gales, P. E. (2018) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001999 · Cited by 16
GI Bleeding Risk of DOACs Versus Warfarin: Is Newer Better?
Feagins, L. A., & Weideman, R. A. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5060-1 · Cited by 16
Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future
Wehbe, R. M., & Yadlapati, A. (2016) · Texas Heart Institute Journal · doi:10.14503/thij-16-5785 · Cited by 14
SAMe-TT 2 R 2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI 2 experience
Kataruka, A., Kong, X., Haymart, B., Kline-Rogers, E. M., ALMANY, S. L., Kozłowski, J., Krol, G. D., Kaatz, S., McNamara, M. W., Froehlich, J. B., et al. (2017) · Vascular Medicine · doi:10.1177/1358863x16682863 · Cited by 15
Self-citation
Age is just a number: A look at “elderly” sport-related traumatic injuries at a level I trauma center
Kay, A. B., Wilson, E. L., White, T. W., Morris, D. S., & Majercik, S. D. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.11.030 · Cited by 15
Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization
Khachatryan, T., Hauschild, C., Hoff, J., Contractor, T. A., Khachatryan, A., Tran, H. N., Matsuo, B., Jacobson, A. K., & Hilliard, A. A. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00344-6 · Cited by 15
Drug interactions with oral anticoagulants in German nursing home residents: comparison between vitamin K antagonists and non-vitamin K antagonist oral anticoagulants based on two nested case–control studies
Jobski, K., Hoffmann, F., Herget‐Rosenthal, S., & Dörks, M. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01526-7 · Cited by 17
Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service
Packard, A. T., Delate, T., Martinez, K. D., & Clark, N. P. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.036 · Cited by 15
Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms
Wiethorn, E. E., Bell, C. M., & Wiggins, B. S. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00470-0 · Cited by 15
VKORC1 variants as significant predictors of warfarin dose in Emiratis
Al-Mahayri, Z. N., Jaibeji, H. S. A., Saab, Y. B., Soliman, K., Al‐Gazali, L., Patrinos, G. P., & Ali, B. R. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s187350 · Cited by 15
Pain in the hip: Spontaneous retroperitoneal hemorrhage in an elderly patient on apixaban
Khan, A., Mastenbrook, J. D., & Bauler, L. D. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.12.049 · Cited by 15
Association of Reversal of Anticoagulation Preoperatively on 30-Day Mortality and Outcomes for Hip Fracture Surgery
Yoo, M. S., Zhu, S., Jiang, S., Hammer, H. L., McBride, W. J., McCarthy, C. M., Green, C. E., & Ananias, M. P. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.01.002 · Cited by 15
Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies
Schreuder, M., Reitsma, P. H., & Bos, M. H. A. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1709134 · Cited by 15
Prevention and Treatment of Bleeding with Direct Oral Anticoagulants
Crawley, R. M., & Anderson, R. L. (2020) · Drugs · doi:10.1007/s40265-020-01345-5 · Cited by 15
From Activated Partial Thromboplastin Time to Antifactor Xa and Back Again
May, J. E., Siniard, R. C., Taylor, L. J., Marques, M. B., & Gangaraju, R. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab135 · Cited by 14
Root Cause Analysis of Adverse Events in an Outpatient Anticoagulation Management Consortium
GRAVES, C. M., Haymart, B., Kline-Rogers, E. M., Barnes, G. D., Perry, L. K., Pluhatsch, D., Gearhart, N., Gikas, H., Ryan, N., & Kurtz, B. (2017) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2017.03.007 · Cited by 14
Self-citation
Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism
Lim, H. Y., Nandurkar, H. H., & Ho, P. W. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0038-1637750 · Cited by 15
Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
DiMaria, C. N., Hanna, W., Murone, J. N., & Reichart, J. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-230371 · Cited by 14
Repeat computed tomography head scan is not indicated in trauma patients taking novel anticoagulation: A multicenter study
Cohan, C. M., Beattie, G., Bowman, J. A., Galante, J. M., Kwok, A. M., Dirks, R. C., Kornblith, L. Z., Plevin, R. E., Browder, T. D., & Victorino, G. P. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002760 · Cited by 14
A smartphone application for remote adjustment of warfarin dose: Development and usability study
Jiang, S., Lv, M., Wu, T., Chen, W., & Zhang, J. (2021) · Applied Nursing Research · doi:10.1016/j.apnr.2021.151521 · Cited by 14
Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function
Limdi, N. A., Beasley, T. M., Sun, J., Stockbridge, N., Pacanowski, M. A., & Florian, J. A. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2131 · Cited by 13
Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation
Barakakis, P. A., Kokkinidis, D. G., Li, W., Nagraj, S., Peppas, S., Kladas, M., Schizas, D., Korantzopoulos, P. G., & Ntaios, G. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001796 · Cited by 13
Traumatic Brain Injury in Patients under Anticoagulant Therapy: Review of Management in Emergency Department
Menditto, V. G., Rossetti, G., Sampaolesi, M., Buzzo, M. A., & Pomponio, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133669 · Cited by 13
Surgical care of the geriatric patient
Katz, M., Silverstein, N., Coll, P. P., Sullivan, G. M., Mortensen, E. M., Sachs, A., Gross, J. B., Girard, E. D., Liang, J., Ristau, B. T., et al. (2019) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2019.03.003 · Cited by 13
Direct oral anticoagulant– versus vitamin K antagonist–related gastrointestinal bleeding: Insights from a nationwide cohort
Butt, J. H., Li, A., Xian, Y., Peterson, E. D., Garcia, D. A., Torp-Pedersen, C. T., Køber, L., & Fosbøl, E. L. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.07.012 · Cited by 13
Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
Pyykönen, M., Linna, M., Tykkyläinen, M., Delmelle, E. M., & Laatikainen, T. K. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-07125-5 · Cited by 13
Genotype-guided dosing of warfarin through modeling and simulation
Deng, J., Vozmediano, V., Rodríguez, M., Cavallari, L. H., & Schmidt, S. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.017 · Cited by 13
Combining oral anticoagulation and antiplatelet therapies: appropriate patient selection
Vandiver, J. W., & Beavers, K. D. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1635-0 · Cited by 13
Management of Bleeding in Patients Taking Oral Anticoagulants
Anderson, I. J., & Cifu, A. S. (2018) · JAMA · doi:10.1001/jama.2018.3504 · Cited by 13
Andexanet alfa for the reversal of factor Xa inhibitors
Favresse, J., Hardy, M. J., van Dievoet, M., Sennesael, A., Douxfils, J., Samama, C. M., Vornicu, O., Dincq, A.-S., Lessire, S., & Mullier, F. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1599355 · Cited by 13
Idarucizumab in major trauma patients: a single centre real life experience
Oberladstätter, D., Voelckel, W., Bruckbauer, M., Zipperle, J., Grottke, O., Ziegler, B., & Schöchl, H. (2019) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-019-01233-y · Cited by 13
Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding
Sheikh‐Taha, M., & Crawley, R. M. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00383-z · Cited by 13
Perioperative Management of Anticoagulants in Ocular Surgeries
He, X., Chen, A. F., Nirwan, R. S., Sridhar, J. S., & Kuriyan, A. E. (2020) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000316 · Cited by 13
Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment
Ting, C., Rhoten, M. N., Dempsey, J., Nichols, H., Fanikos, J. R., & Ruff, C. T. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620987900 · Cited by 13
Relationship between International Normalized Ratio and Outcomes in Modern Trials with Warfarin Controls
McDowell, T., Lawrence, J., Florian, J. A., Southworth, M. R., Grant, S. N., & Stockbridge, N. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2161 · Cited by 13
Antithrombotic Agent Use in Elderly Patients Sustaining Low-Level Falls
Meade, M. J., Tumati, A., Chantachote, C. J., Huang, E. C., Rutigliano, D. N., Rubano, J. A., Vosswinkel, J. A., & Jawa, R. S. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.08.047 · Cited by 12
Traumatic Brain Injury in Patients Receiving Direct Oral Anticoagulants
Santing, J. A. L., van den Brand, C. L., & Jellema, K. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.09.012 · Cited by 12
An observational epidemiological study to analyze intracerebral hemorrhage across the United States: Incidence and mortality trends from 1990 to 2017
DeLago, A. J., Singh, H., Jani, C., Rupal, A., Shalhoub, J., Goodall, R. J., Shah, D., Hartley, A., Hammond‐Haley, M., Marshall, D. C., et al. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.106216 · Cited by 12
Prescribing Trends of Oral Anticoagulants from 2010 to 2020 in Shanghai, China: A Retrospective Study
Zhang, C., Wang, J., Yang, Y. J., Ma, E.-L., Lin, H., Liu, B.-L., & Gu, Z.-C. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221132551 · Cited by 12
Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study
Singer, A. J., Concha, M., Williams, J. D., Brown, C. S., Fernandes, R., Thode, H. C., Kirchman, M., & Rabinstein, A. A. (2023) · Western Journal of Emergency Medicine · doi:10.5811/westjem.60587 · Cited by 12
Use of direct oral anticoagulants for treatment of atrial fibrillation in patients with HIV
West, T. A., Perram, J., & Holloway, C. J. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000412 · Cited by 12
Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience
Elewa, H. F., El-Makaty, H., & Ali, Z. O. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417731536 · Cited by 12
Reversal Agents in the Era of NOACs: 2017 Update
Sy, R. W. (2017) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1634 · Cited by 12
Patterns in anticoagulant utilization in the Czech Republic during 2007–2017
Malý, J., Dvorackova, S., Zimčíková, E., Kuběna, A. A., Kolar, J., Vlček, J., Penka, M., & Malá‐Ládová, K. (2019) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-019-01806-z · Cited by 12
Impact of Anticoagulant and Antiplatelet Use on Outcomes in Blunt Chest Injury
Udekwu, P. O., Roy, S., Stiles, A. L., Dibbert, A., Nguyen, M., & Rice, V. (2019) · The American Surgeon · doi:10.1177/000313481908500841 · Cited by 12
Randomized controlled trial of genotype‐guided warfarin anticoagulation in Chinese elderly patients with nonvalvular atrial fibrillation
Zhu, Y., Xu, C., & Liu, J. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13218 · Cited by 12
Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients
Jin, M. C., Sussman, E. S., Feng, A. Y., Han, S. S., Skirboll, S. L., Berube, C., & Ratliff, J. K. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.06.015 · Cited by 12
Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center
Patel, S. M., Wang, T. J., Outler, D. L., Elliott, J., Knauss, M. D., Peasah, S. K., & Akbashev, M. Y. (2019) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-019-01959-x · Cited by 11
Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis
Katel, A., Aryal, M. R., Neupane, A., Gosain, R., Pathak, R., Bhandari, Y., & Kouides, P. A. (2021) · Cureus · doi:10.7759/cureus.14572 · Cited by 11
Nonoperative management of blunt abdominal solid organ injury: Are we paying enough attention to patients on preinjury anticoagulation?
Reina, R., Anand, T., Bhogadi, S. K., Nelson, A. J., Hosseinpour, H., Ditillo, M. F., El-Qawaqzeh, K. W. M., Castañón, L., Stewart, C., & Joseph, B. A. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.06.019 · Cited by 11
Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed‐methods study
Barnes, G. D., Acosta, J., Graves, C., Puroll, E., Kline-Rogers, E. M., Gu, X., Townsend, K., McMahon, E. L., Craig, T. L., & Froehlich, J. B. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12157 · Cited by 11
Self-citation
Recommendations for Research Assessing Outcomes for Patients With Anticoagulant-Related Intracerebral Bleeds
Concha, M., & Cohen, A. T. (2021) · Stroke · doi:10.1161/strokeaha.120.031730 · Cited by 11
A single‐institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting
Hazim, A. Z., Ruan, G. J., Khodadadi, R. B., Slusser, J. P., Marshall, A. L., & Pruthi, R. K. (2021) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13727 · Cited by 11
How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia
Tan, S. L., Yong, Z. Y., Liew, J. E. S., Zainal, H., & Siddiqui, S. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00377-w · Cited by 12
Usefullness of Heparin Calibrated Anti-Xa Activity to Assess Anticoagulant Activity of Apixaban and Rivaroxaban in Emergency Patients Scheduled for Acute Interventions
Riahi, N., Rozen, L., & Demulder, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216785 · Cited by 10
Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial
Lee, T. M.-H., Ivers, N. M., Bhatia, S., Butt, D. A., Dorian, P., Jaakkimainen, L., Leblanc, K., Legge, D., Morra, D. J., Valentinis, A., et al. (2016) · Implementation Science · doi:10.1186/s13012-016-0523-2 · Cited by 10
Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center
Leary, E. J. W., Brilliant, M. H., Peissig, P. L., & Griesbach, S. A. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxy072 · Cited by 10
Acute and delayed intracranial hemorrhage in head-injured patients on warfarin versus direct oral anticoagulant therapy
Hughes, P., Alter, S. M., Greaves, S. W., Mazer, B. A., Solano, J. J., Shih, R. D., Clayton, L. M., Trinh, N. Q., Lottenberg, L. L., & Hughes, M. J. (2021) · Journal of Emergencies Trauma and Shock · doi:10.4103/jets.jets_139_20 · Cited by 10
Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
Joyce, E. V., Haymart, B., Kong, X., Ali, M. A., Carrigan, M., Kaatz, S. S., Shah, V. I., Kline-Rogers, E. M., Kozłowski, J., Froehlich, J. B., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025471 · Cited by 11
Self-citation
Modified Brain Injury Guidelines for preinjury anticoagulation in traumatic brain injury: An opportunity to reduce health care resource utilization
Gallagher, S. P., Capacio, B. A., Rooney, A. S., Schaffer, K. B., Calvo, R. Y., Sise, C. B., Krzyzaniak, A., Sise, M. J., Bansal, V., Biffl, W. L., et al. (2023) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004171 · Cited by 10
Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa
Barton, C. A., Hom, M., Johnson, N. B., Case, J., Ran, R., & Schreiber, M. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2017.12.011 · Cited by 10
Warfarin Use and Mortality, Stroke, and Bleeding Outcomes in a Cohort of Elderly Patients with non-Valvular Atrial Fibrillation
Bradshaw, P. J., Hung, J., Knuiman, M. W., Briffa, T. G., Nedkoff, L. J., Katzenellenbogen, J. M., Rankin Jamie, M., & Sanfilippo, F. M. (2019) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2155 · Cited by 10
The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring
Jones, A. E., King, J. B., Kim, K., & Witt, D. M. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02064-0 · Cited by 10
Does the presence of diabetes mellitus confer an increased risk of stroke in patients with atrial fibrillation on direct oral anticoagulants? A systematic review and meta-analysis
Abdool, M., Kunutsor, S. K., Khunti, K. K., & Seidu, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.08.038 · Cited by 10
Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis
Mohamoud, M., Horgan, C. E., Eworuke, E., Dee, E., Bohn, J. M., Shapira, O., Muñoz, M. A., Stojanović, D., Sansing‐Foster, V., Ajao, A. O., et al. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2468 · Cited by 10
Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms
Sun, B., Wen, Y., Culhane‐Pera, K. A., Lo, M., Xiong, T., Lee, K., Peng, K., Thyagarajan, B., Bishop, J. R., Zierhut, H. A., et al. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2487 · Cited by 10
Anticoagulation for Atrial Fibrillation: A Review of Current Literature and Views
Jin, C., Cui, C., Seplowe, M., Lee, K., Vegunta, R., Li, B., Frishman, W. H., & Iwai, S. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000489 · Cited by 10
Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF
McManus, D. D., Kiefe, C. I., Lessard, D., Waring, M. E., Parish, D. C., Awad, H. H., Marino, F., Helm, R. H., Sogade, F., Goldberg, R. J., et al. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00155 · Cited by 12
Bleeding With Direct Oral Anticoagulants: The Gastrointestinal Tract and Beyond
Laine, L. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.041 · Cited by 10
Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study
Huang, C., Duan, L., An, J., Sim, J. J., & Lee, M. S. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07114-8 · Cited by 9
A Physiological-Based Pharmacokinetic Model Embedded with a Target-Mediated Drug Disposition Mechanism Can Characterize Single-Dose Warfarin Pharmacokinetic Profiles in Subjects with Various CYP2C9 Genotypes under Different Cotreatments
Cheng, S., Flora, D. R., Rettie, A. E., Brundage, R. C., & Tracy, T. S. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001048 · Cited by 9
Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis
Park, D. Y., An, S., Arif, A. W., Sana, M. K., & Vij, A. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03067-4 · Cited by 9
Implementing pharmacist-prescriber collaboration to improve evidence-based anticoagulant use: a randomized trial
Smith, S. N., Lanham, M. S. M., Seagull, F. J., Dorsch, M. P., Errickson, J., & Barnes, G. D. (2023) · Implementation Science · doi:10.1186/s13012-023-01273-4 · Cited by 10
Self-citation
Use of Direct Oral Anticoagulants Among Patients With Hip Fracture Is Not an Indication to Delay Surgical Intervention
Brameier, D. T., Tischler, E. H., Ottesen, T. D., McTague, M. F., Appleton, P. T., Harris, M. B., Weaver, M. J., & Suneja, N. (2024) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002753 · Cited by 9
To Hold or Continue Blood Thinners? A Retrospective Analysis on Outcomes of Holmium Laser Enucleation of the Prostate in Patients Who Either Held or Continued Antiplatelet/Anticoagulation Therapy
Xu, P. J., Dean, N. S., Tsai, K. P., Ganesh, M., Khondakar, N. R., Guo, J. N., & Krambeck, A. E. (2024) · Urology · doi:10.1016/j.urology.2024.08.050 · Cited by 9
The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro
Bunce, M. W., Devine, Z. H., & Chintala, M. S. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102600 · Cited by 9
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
Short, S., Wilkinson, K. S., Hald, E. M., Howard, G., Howard, V. J., Judd, S. E., Soliman, E. Z., D, B. M. K. M., Robinson, D., Stanton, R. J., et al. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.06.007 · Cited by 9
Traumatic Intracranial Hemorrhage on CT After Ground-Level Fall in Adult Patients Receiving Antithrombotic Therapy: A Retrospective Case-Control Study
Vardar, Z., Lo, H. S., Mariyampillai, M., & Kotecha, H. M. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.21.27274 · Cited by 9
The Impact of Clinical Pharmacy Services on Direct Oral Anticoagulant Medication Selection and Dosing in the Ambulatory Care Setting
Yates, N. Y., Hale, S. A., & Clark, N. P. (2023) · Journal of Pharmacy Practice · doi:10.1177/08971900231166555 · Cited by 9
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study
Otoshi, T., Kataoka, Y., Nakagawa, A., Otsuka, K., & Tomii, K. (2016) · Lung · doi:10.1007/s00408-016-9873-4 · Cited by 9
The Reversal of Direct Oral Anticoagulants in Animal Models
Honickel, M., Akman, N., & Grottke, O. (2017) · Shock · doi:10.1097/shk.0000000000000848 · Cited by 9
Periprocedural Bridging Anticoagulation: Measuring the Impact of a Clinical Trial on Care Delivery
Barnes, G. D., Li, Y., Gu, X., Haymart, B., Kline-Rogers, E. M., ALMANY, S. L., Kozłowski, J., Krol, G. D., McNamara, M. W., Froehlich, J. B., et al. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.07.027 · Cited by 9
Self-citation
TREATMENT OF ATRIAL FIBRILLATION IN NURSING HOMES: A PLACE FOR DIRECT ACTING ORAL ANTICOAGULANTS?
Alcusky, M. J., & Lapane, K. L. (2018) · The Journal of Nursing Home Research Sciences · doi:10.14283/jnhrs.2018.4 · Cited by 9
Management and outcomes of isolated interhemispheric subdural hematomas associated with falx syndrome
Tonetti, D. A., Ares, W. J., Okonkwo, D. O., & Gardner, P. A. (2019) · Journal of neurosurgery · doi:10.3171/2018.8.jns181812 · Cited by 9
Moving towards ideal and appropriate models of anticoagulation management service
Anakwue, R. C. (2020) · Annals of African Medicine · doi:10.4103/aam.aam_30_19 · Cited by 9
Multi‐site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos
Rouby, N. E., Marcatto, L. R., Claudio, K., Tavares, L. C., Steiner, H., Botton, M., Lubitz, S., Fallon, E., Yee, K. C., Kaye, J. B., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12854 · Cited by 8
Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance
Moudallel, S., van den Eynde, C., Malý, J., Rydant, S., & Steurbaut, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02388-7 · Cited by 9
Early Hemorrhagic Complications after Holmium Laser Enucleation of the Prostate in Patients Undergoing Antithrombotic Therapy: A Retrospective Analysis from a High-Volume Centre
Pastore, S., Carilli, M., Nicola, S. D., Campagna, A., Parente, U., Pierella, F., D’Ippolito, G., Agrò, E. F., & Zuccalà, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13196006 · Cited by 8
Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology
Fukamachi, D., Hirayama, A., Miyauchi, K., Yasuda, S., Ogawa, H., Ito, H., & Daida, H. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.01.017 · Cited by 8
Expert Consensus Decision Pathway of the American College of Cardiology on Management of Bleeding in Patients With Oral Anticoagulants: A Review of the 2020 Update for Perioperative Physicians
Navas‐Blanco, J. R., Martini, A., & Fabbro, M. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.02.024 · Cited by 9
Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial
Kurlander, J. E., Helminski, D., Lanham, M. S. M., Henstock, J. L., Kidwell, K., Krein, S. L., Saini, S. D., Richardson, C. R., Vries, R. G. D., Resnicow, K., et al. (2022) · Implementation Science Communications · doi:10.1186/s43058-022-00256-8 · Cited by 8
Self-citation
Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism
Reda, S., Rudde, E., Müller, J., Hamedani, N. S., Oldenburg, J., Pötzsch, B., & Rühl, H. (2022) · Life · doi:10.3390/life12050705 · Cited by 8
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review
Sheklabadi, E., Sharifi, Y., Tabarraee, M., Tamehrizadeh, S. S., Rabiee, P., & Hadaegh, F. (2022) · Thrombosis Journal · doi:10.1186/s12959-022-00397-9 · Cited by 8
The BRIDGE trial: What the hospitalist should know
Nazha, B., & Spyropoulos, A. C. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2594 · Cited by 8
Anticoagulation and Neuraxial/Peripheral Anesthesia
Kaushal, M., Rubin, R. E., Kaye, A. D., & Gritsenko, K. (2017) · Anesthesiology Clinics · doi:10.1016/j.anclin.2017.01.002 · Cited by 8
Andexanet Alfa for Reversing Factor Xa Inhibition
Sible, A. M., & Nawarskas, J. J. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000230 · Cited by 8
New oral anti-coagulation drugs and prostate biopsy: a call for guidelines
Coscarella, M., Motte, S., Dalati, M.-F., Silva, T. O. E., Entezari, K., & Roumeguère, T. (2018) · Therapeutic Advances in Urology · doi:10.1177/1756287218811037 · Cited by 8

Authors: Barnes, G. D., Lucas, E., Alexander, G. C., & Goldberger, Z. D.
Affiliations: University of Michigan (US)
Johns Hopkins University (US)
University of Washington (US)
Corresponding author: Barnes, Geoffrey D.
ORCID: Barnes, Geoffrey D.
Lucas, Eleanor
Alexander, G. Caleb
Goldberger, Zachary D.
Venue: The American Journal of Medicine
Publisher: Elsevier BV
Published: 2015-12
Volume: 128
Issue: 12
Pages: 1300-1305.e2
ISSN: 0002-9343 (ISSN-L)
DOI: 10.1016/j.amjmed.2015.05.044
PMC: PMC4658248
OpenAlex: W826970266
Cited by: 598
References: 41
Citations by year: 2026: 11 · 2025: 25 · 2024: 23 · 2023: 38 · 2022: 72 · 2021: 69 · 2020: 87 · 2019: 97 · 2018: 83 · 2017: 61 · 2016: 29 · 2015: 1
FWCI: 42.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The American Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01 HL107345, T32 HL007853-16)
Portola Pharmaceuticals
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: direct oral anticoagulants, warfarin, atrial fibrillation, venous thromboembolism, outpatient care, rivaroxaban, apixaban, dabigatran, prescribing patterns, drug adoption
MeSH terms: Rivaroxaban, Dabigatran, Administration, Oral, Adult, Age Factors, Aged, Ambulatory Care, Anticoagulants, Atrial Fibrillation, Female, Humans, Male, Middle Aged, Practice Patterns, Physicians', Pyrazoles, Pyridones, United States, Warfarin, Venous Thromboembolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

National Trends in Ambulatory Oral Anticoagulant Use

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks